FDA-Drug2023-07-19Class III
PANCREAZE (pancrelipase) Delayed-Release Capsules, 100-count bottles, Rx only, Rx only, Manufactured by VIVUS LLC, Campbell, CA 95008, UPC: N3 62541-401-10 5, NDC 62541-401-10,
Vivus, Inc.
Hazard
Failed Stability Specifications
Sold states
Nationwide within the United States
Affected count
4240 bottles
Manufactured in
900 E Hamilton Ave Ste 550, N/A, Campbell, CA, United States
Products
PANCREAZE (pancrelipase) Delayed-Release Capsules, 100-count bottles, Rx only, Rx only, Manufactured by VIVUS LLC, Campbell, CA 95008, UPC: N3 62541-401-10 5, NDC 62541-401-10,
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0896-2023Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief